Liver Transplants Improved Survival for Severe ACLF
The international CHANCE study found that transplants significantly reduced mortality rates for patients with advanced liver failure.
Updated on Oct. 14, 2026 in Life Sciences
Live Poll
Should patients with multiple organ failures be prioritized for life-saving liver transplants?
New research has confirmed that liver transplants significantly improve survival rates for patients suffering from severe acute-on-chronic liver failure (ACLF). The CHANCE study showed that transplantation offers a viable treatment path for conditions that were previously considered contraindications.
Why it matters
This study clarifies the role of liver transplantation in treating severe ACLF, a condition that previously lacked standardized transplant protocols. These findings provide critical data to guide clinical decision-making for patients with high mortality risks while waiting for donor organs.
The CHANCE study monitored 995 patients across 63 centers using standardized procedures to collect clinical data and biological samples. Researchers specifically analyzed outcomes for 612 transplant recipients compared to a control group of 144 non-transplanted individuals.
The players
CHANCE study
This is an international research project that investigated the outcomes of liver transplantation for patients with severe acute-on-chronic liver failure.
Journal of Hepatology
This is a peer-reviewed medical journal that publishes original research and clinical studies on liver diseases and hepatology.
Hospital Clínic Barcelona
This is a major university hospital in Spain that serves as a leading hub for medical research and clinical care in hepatology.
The details
The study revealed that while transplantation is highly effective, patients presenting with five or six organ failures face a 41.7% mortality rate post-surgery. Risks are particularly elevated for individuals experiencing respiratory, circulatory, or neurological failures.
Timeline
Patients were followed as part of the study from 2021 to 2023.
The results were published in the Journal of Hepatology on September 30, 2026.
The Big Picture
The findings from the CHANCE study shift the current paradigm by redefining which patients are eligible for life-saving liver transplants. This research bridges a critical gap in hepatology by providing empirical evidence for procedures previously debated in clinical practice.
This research could fundamentally change how transplant centers evaluate candidates with multi-organ failure, potentially increasing access to surgery for the most critical patients. These data-driven criteria help medical teams better predict post-operative success and manage resources more effectively.
The takeaway
Patients and medical providers should note that while liver transplants significantly boost survival odds, the severity of organ failure remains a key predictor of recovery success. Consulting with specialized transplant centers is essential for patients managing acute-on-chronic liver failure.
Further reading
For more information on clinical advancements, visit the Life Sciences section.
Source note: This article includes information reported by Biotech-spain.
Live Poll
Should patients with multiple organ failures be prioritized for life-saving liver transplants?
